Clinical Research Directory
Browse clinical research sites, groups, and studies.
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
Sponsor: Alnylam Pharmaceuticals
Summary
This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.
Official title: ELEVATE, a Global Observational Longitudinal Prospective Registry of Patients With Acute Hepatic Porphyria (AHP)
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2021-04-26
Completion Date
2027-04-01
Last Updated
2026-02-17
Healthy Volunteers
No
Conditions
Locations (30)
Clinical Trial Site
Birmingham, Alabama, United States
Clinical Trial Site
Gilbert, Arizona, United States
Clinical Trial Site
San Francisco, California, United States
Clinical Trial Site
Baltimore, Maryland, United States
Clinical Trial Site
Boston, Massachusetts, United States
Clinical Trial Site
Minneapolis, Minnesota, United States
Clinical Trial Site
New York, New York, United States
Clinical Trial Site
Winston-Salem, North Carolina, United States
Clinical Trial Site
Oklahoma City, Oklahoma, United States
Clinical Trial Site
Philadelphia, Pennsylvania, United States
Clinical Trial Site
Galveston, Texas, United States
Clinical Trial Site
Salt Lake City, Utah, United States
Clinical Trial Site
Seattle, Washington, United States
Clinical Trial Site
Brussels, Belgium
Clinical Trial Site
Leuven, Belgium
Clinical Trial Site
Bordeaux, France
Clinical Trial Site
Paris, France
Clinical Trial Site
Toulouse, France
Clinical Trial Site
Berlin, Germany
Clinical Trial Site
Chemnitz, Germany
Clinical Trial Site
Würzburg, Germany
Clinical Trial Site
Milan, Italy
Clinical Trial Site
Modena, Italy
Clinical Trial Site
Madrid, Spain
Clinical Trial Site
Stockholm, Sweden
Clinical Trial Site
Zurich, Switzerland
Clinical Trial Site
Taichung, Taiwan
Clinical Trial Site
Taipei, Taiwan
Clinical Trial Site
Cardiff, United Kingdom
Clinical Trial Site
London, United Kingdom